LONDON (Alliance News) - Circassia Pharmaceuticals PLC said Friday it has seen positive results from a two-year follow up of a phase IIb study of a house dust mite allergy product HDM-SPIRE. Investigators reassessed patients' allergy symptoms two years after starting treatment with the prod Read More

Imperial Innovation Looks To Raise GBP150.0 Million In Share Placing

2nd Jun 2014 09:13

LONDON (Alliance News) - Imperial Innovations Group PLC Monday detailed plans to raise up to GBP150.0 million before expenses through a share placing with new and existing investors, as it looks to support its existing portfolio companies, source opportunities to invest in new technologies, and f Read More

Circassia Pharmaceuticals Funded To Progress With Allergy Treatments

19th May 2014 13:11

LONDON (Alliance News) - Clinical-stage specialty biopharmaceutical company Circassia Pharmaceuticals PLC Monday said it is fully-funded to continue the development of its SPIRE product portfolio and bringing CAT-SPIRE to the market after raising over GBP200 million though an initial public offer Read More

IPO Statistics: London Main Market 2014

21st Mar 2014 15:31

DIRECTOR DEALINGS: Circassia Phamaceuticals CEO, Non-Executive Transfer Shares

18th Mar 2014 17:05

LONDON (Alliance News) - Circassia Pharmaceuticals PLC Tuesday said Chief Executive Steven Harris and non-executive Director Charles Swingland transfered shares into family trusts Thursday.<br /><br />Details are as follows. <table class="bq" style="width: 589px; height: 136px;" cellspacing Read More

Dalata Hotel Group IPO Oversubscribed

18th Mar 2014 14:00

LONDON (Alliance News) - Dalata Hotel Group PLC Tuesday said it has raised EUR265 million gross through a placing of 106 million shares under its float on AIM, with the net proceeds earmarked for the acquisition of a portfolio of 16 to 25 hotels throughout Ireland and to pay down its debt. Read More

1 2 3 4 5 6 78

FTSE 100 Latest

Value8,809.74

Change53.53